Switch to:
More From Other Websites
How Did Novartis Perform in 3Q16? Jan 16 2017
5 Trump-Proof Pharma Dividends Up To 5.3% Jan 16 2017
Odds Are Against Regeneron, Sanofi In Amgen Patent Battle: Leerink Jan 13 2017
Sanofi, ImmuNext Sign $500M Autoimmune Drug Pact Jan 13 2017
Insulin Drug Offers Hope for MannKind Jan 12 2017
Regeneron, Sanofi's Drug Manufacturing Plant Cleared Jan 12 2017
Sanofi, ImmuNext Ink Deal, Focus on Autoimmune Diseases Jan 10 2017
The Zacks Analyst Blog Highlights: Clovis Oncology, Pfizer, Roche's, Sanofi and Regeneron... Jan 10 2017
Amgen Inks Multiple Deals, Offers Update on Repatha Lawsuit Jan 10 2017
Sanofi Sees No Opening to Actelion Talks After J&J Re-Entry Jan 09 2017
Morgan Stanley Cuts Regeneron Target On Praluent Patent Worries Jan 09 2017
Impax (IPXL) Applies for Generic Aubagio; Sanofi Files Lawsuit Jan 09 2017
Sanofi and ImmuNext Enter into Agreement to Develop Treatments for Autoimmune Diseases Jan 09 2017
[$$] Regeneron Is Down, Not Out Jan 08 2017
In the age of Uber and Lyft, it’s still hard for some Americans to get to the doctor Jan 07 2017
Judge’s unusual ruling on Amgen, Regeneron patent case puts billions of dollars at stake Jan 07 2017
Sanofi Investors Count Cost of Praluent Ruling Jan 06 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK